Cargando…
Metabolism in Retinopathy of Prematurity
Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retina...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620873/ https://www.ncbi.nlm.nih.gov/pubmed/34832995 http://dx.doi.org/10.3390/life11111119 |
_version_ | 1784605323654332416 |
---|---|
author | Tomita, Yohei Usui-Ouchi, Ayumi Nilsson, Anders K. Yang, Jay Ko, Minji Hellström, Ann Fu, Zhongjie |
author_facet | Tomita, Yohei Usui-Ouchi, Ayumi Nilsson, Anders K. Yang, Jay Ko, Minji Hellström, Ann Fu, Zhongjie |
author_sort | Tomita, Yohei |
collection | PubMed |
description | Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retinal neovessel growth. Current therapeutic interventions target the hypoxia-induced neovessels but negatively impact retinal neurons and normal vessels. Emerging evidence suggests that metabolic disturbance is a significant and underexplored risk factor in the disease pathogenesis. Hyperglycemia and dyslipidemia correlate with the retinal neurovascular dysfunction in infants born prematurely. Nutritional and hormonal supplementation relieve metabolic stress and improve retinal maturation. Here we focus on the mechanisms through which metabolism is involved in preterm-birth-related retinal disorder from clinical and experimental investigations. We will review and discuss potential therapeutic targets through the restoration of metabolic responses to prevent disease development and progression. |
format | Online Article Text |
id | pubmed-8620873 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86208732021-11-27 Metabolism in Retinopathy of Prematurity Tomita, Yohei Usui-Ouchi, Ayumi Nilsson, Anders K. Yang, Jay Ko, Minji Hellström, Ann Fu, Zhongjie Life (Basel) Review Retinopathy of prematurity is defined as retinal abnormalities that occur during development as a consequence of disturbed oxygen conditions and nutrient supply after preterm birth. Both neuronal maturation and retinal vascularization are impaired, leading to the compensatory but uncontrolled retinal neovessel growth. Current therapeutic interventions target the hypoxia-induced neovessels but negatively impact retinal neurons and normal vessels. Emerging evidence suggests that metabolic disturbance is a significant and underexplored risk factor in the disease pathogenesis. Hyperglycemia and dyslipidemia correlate with the retinal neurovascular dysfunction in infants born prematurely. Nutritional and hormonal supplementation relieve metabolic stress and improve retinal maturation. Here we focus on the mechanisms through which metabolism is involved in preterm-birth-related retinal disorder from clinical and experimental investigations. We will review and discuss potential therapeutic targets through the restoration of metabolic responses to prevent disease development and progression. MDPI 2021-10-21 /pmc/articles/PMC8620873/ /pubmed/34832995 http://dx.doi.org/10.3390/life11111119 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Tomita, Yohei Usui-Ouchi, Ayumi Nilsson, Anders K. Yang, Jay Ko, Minji Hellström, Ann Fu, Zhongjie Metabolism in Retinopathy of Prematurity |
title | Metabolism in Retinopathy of Prematurity |
title_full | Metabolism in Retinopathy of Prematurity |
title_fullStr | Metabolism in Retinopathy of Prematurity |
title_full_unstemmed | Metabolism in Retinopathy of Prematurity |
title_short | Metabolism in Retinopathy of Prematurity |
title_sort | metabolism in retinopathy of prematurity |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8620873/ https://www.ncbi.nlm.nih.gov/pubmed/34832995 http://dx.doi.org/10.3390/life11111119 |
work_keys_str_mv | AT tomitayohei metabolisminretinopathyofprematurity AT usuiouchiayumi metabolisminretinopathyofprematurity AT nilssonandersk metabolisminretinopathyofprematurity AT yangjay metabolisminretinopathyofprematurity AT kominji metabolisminretinopathyofprematurity AT hellstromann metabolisminretinopathyofprematurity AT fuzhongjie metabolisminretinopathyofprematurity |